![James Ryan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
James Ryan
Algemeen Adviseur bij
BIONTECH SE
Vermogen: 446 175 $ op 30-06-2026
Profiel
James Ryan currently works at Law Society of Ireland, as Member and BioNTech SE, as Chief Legal & Business Officer from 2024.
Dr. Ryan also formerly worked at GW Pharmaceuticals Ltd., as Head-Legal Affairs.
Dr. Ryan received his doctorate degree from the University of St. Andrews School of Management.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 12-05-2026 | 4.795 ( 0% ) | 446 175 $ | 30-06-2026 |
Actieve functies van James Ryan
| Bedrijven | Functie | Begin |
|---|---|---|
| BIONTECH SE | Algemeen Adviseur | 01-07-2018 |
Law Society of Ireland | Corporate Officer/Principal | - |
Eerdere bekende functies van James Ryan
| Bedrijven | Functie | Einde |
|---|---|---|
| GW PHARMACEUTICALS PLC | Algemeen Adviseur | - |
Opleiding van James Ryan
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
12
Eerstegraads connecties
4
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
GW Pharmaceuticals Ltd.
 GW Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops and markets novel therapeutics | Health Technology |
Law Society of Ireland | |
BioNTech SE
 BioNTech SE BiotechnologyHealth Technology Develops immunotherapies and mRNA-based vaccines to treat cancer & infectious diseases | Health Technology |
University of St. Andrews School of Management
 University of St. Andrews School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kies MarketScreener 
